![](/img/cover-not-exists.png)
P-231A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer
Picozzi, Vincent, Sahai, Vaibhav, Simeone, Diane, Rocha Lima, Caio, Ocean, Allyson, Philip, Philip, Saif, Wasif, Kalyan, Aparna, Ondovik, Michael, Shiansong Li, Jack, Louis, ChrystalVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx261.229
Date:
June, 2017
File:
PDF, 144 KB
english, 2017